Patents Assigned to ORTHOCELL LIMITED
  • Publication number: 20230174943
    Abstract: The invention pertains to the technical field of a method for isolating and expanding tendon cells in vitro. The invention also relates to cellular compositions comprising such tendon cells and use thereof to repair tendon tissue. In particular, the present invention relates to a cellular composition comprising isolated tendon cells which cells express tenomodulin (TNMD) and scleraxis (Scx).
    Type: Application
    Filed: December 6, 2021
    Publication date: June 8, 2023
    Applicant: Orthocell Limited
    Inventors: Ming-Hao Zheng, Monique Cannon
  • Patent number: 11517419
    Abstract: There is disclosed a collagen construct comprising a plurality of elongate strips, wherein each strip contains a plurality of collagen fibres that are substantially aligned along the length of the respective strips, and the strips are braided or woven together to produce a collagen construct in the form of a rope that can be used for replacing tendons or ligaments, such as cruciate ligaments. Also disclosed is a method for making or producing the collagen construct from a collagen membrane having a plurality of collagen fibres being substantially aligned parallel to each other in a common direction. The membrane is cut along cut lines that are orientated substantially parallel to that common direction, thereby to separate elongate strips from the membrane. The strips are then braided or woven together to form the collagen construct.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: December 6, 2022
    Assignee: Orthocell Limited
    Inventor: Ming Hao Zheng
  • Patent number: 10524895
    Abstract: There is disclosed a collagen construct comprising a plurality of elongate strips, wherein each strip contains a plurality of collagen fibres that are substantially aligned along the length of the respective strips, and the strips are braided or woven together to produce a collagen construct in the form of a rope that can be used for replacing tendons or ligaments, such as cruciate ligaments. Also disclosed is a method for making or producing the collagen construct from a collagen membrane having a plurality of collagen fibres being substantially aligned parallel to each other in a common direction. The membrane is cut along cut lines that are orientated substantially parallel to that common direction, thereby to separate elongate strips from the membrane. The strips are then braided or woven together to form the collagen construct.
    Type: Grant
    Filed: October 12, 2015
    Date of Patent: January 7, 2020
    Assignee: Orthocell Limited
    Inventor: Ming Hao Zheng
  • Patent number: 9889233
    Abstract: A medical composition is disclosed, which is injectable and which comprises a mixture of native components, which are obtainable by culturing one or more cell samples from a human or animal during normal conditions, said native components being included in the group consisting of growth factors, extracellular matrix proteins, and other substances produced by said cell samples during normal conditions, and a pharmaceutically acceptable carrier, as well as a method for producing the native components, a method for producing the medical composition, a method for treating a subject in need of tissue repair by injection of the medical composition, and use of said mixture of native components for the production of said medical composition for tissue repair via injection.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: February 13, 2018
    Assignee: ORTHOCELL LIMITED
    Inventor: Lars Lidgren
  • Publication number: 20170224344
    Abstract: The present invention relates to a sutureless method of repairing soft tissue defects in soft tissue including ligaments such as anterior cruciate ligaments (ACLs). In particular, the present invention relates a sutureless method of repairing soft tissue defect comprising: (i) providing a collagen-containing patch adapted to enclose at least a portion of said soft tissue defect; (ii) contacting said soft tissue defect and/or collagen-containing patch with a sensitizer; (Hi) enclosing said soft tissue defect in said collagen-containing patch to produce a bioactive chamber; and (iv) adhering said collagen-containing patch to said soft tissue defect without sutures.
    Type: Application
    Filed: October 12, 2015
    Publication date: August 10, 2017
    Applicant: ORTHOCELL LIMITED
    Inventor: Ming Hao Zheng